Subscribe For Free! Sign up to receive the print magazine six times per year and the e-mail newsletter twice a month. Learn more >
• Biopharmaceutical and biomedical technologies and treatments will be advanced in large part by developing countries. Although only 5% to 7% of biological products now in clinical development will actually make it to the market, they will play an important role as the life sciences industry begins to develop custom solutions for individual patients rather than focusing exclusively on the larger market. But such treatments will require a change in packaging and processing methods, as well as regulatory procedures.
At the recently concluded interpack, the exhibitors were pleased, show sponsor Messe Düsseldorf was happy, and even the weather—for the first four days at least—cooperated. Our take-aways:
